nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—Chest pain—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Famotidine—Arthralgia—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Famotidine—Anxiety—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Famotidine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Famotidine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Famotidine—Dyspepsia—Leflunomide—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Famotidine—Vomiting—Mometasone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Famotidine—Dry mouth—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Famotidine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Famotidine—Rash—Mometasone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Famotidine—Asthenia—Captopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Famotidine—Dermatitis—Mometasone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Famotidine—Decreased appetite—Leflunomide—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Famotidine—Confusional state—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Famotidine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Famotidine—Headache—Mometasone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Famotidine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Famotidine—Fatigue—Leflunomide—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Famotidine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Famotidine—Oedema—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Famotidine—Pruritus—Captopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Famotidine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Famotidine—Pain—Leflunomide—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Famotidine—Constipation—Leflunomide—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Famotidine—Infection—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Famotidine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Famotidine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Famotidine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Famotidine—Shock—Lisinopril—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Famotidine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Famotidine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Famotidine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Famotidine—Neutropenia—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Famotidine—Abdominal pain—Azathioprine—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Famotidine—Body temperature increased—Azathioprine—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Famotidine—Diarrhoea—Captopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Famotidine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Famotidine—Irritability—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Famotidine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Famotidine—Erectile dysfunction—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Famotidine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Famotidine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Famotidine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Famotidine—Nausea—Mometasone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Famotidine—Anorexia—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Famotidine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Famotidine—Pain—Mycophenolic acid—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Famotidine—Constipation—Mycophenolic acid—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Famotidine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Famotidine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Famotidine—Cough—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Famotidine—Dizziness—Captopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Famotidine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000999	0.000999	CcSEcCtD
Famotidine—Depression—Prednisone—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Famotidine—Urticaria—Leflunomide—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Famotidine—Body temperature increased—Leflunomide—systemic scleroderma	0.000988	0.000988	CcSEcCtD
Famotidine—Abdominal pain—Leflunomide—systemic scleroderma	0.000988	0.000988	CcSEcCtD
Famotidine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000983	0.000983	CcSEcCtD
Famotidine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000982	0.000982	CcSEcCtD
Famotidine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000982	0.000982	CcSEcCtD
Famotidine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000982	0.000982	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Famotidine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000978	0.000978	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000977	0.000977	CcSEcCtD
Famotidine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Famotidine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Famotidine—Insomnia—Lisinopril—systemic scleroderma	0.000971	0.000971	CcSEcCtD
Famotidine—Paraesthesia—Lisinopril—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Famotidine—Vomiting—Captopril—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Famotidine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00096	0.00096	CcSEcCtD
Famotidine—Rash—Captopril—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Famotidine—Dermatitis—Captopril—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Famotidine—Somnolence—Lisinopril—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Famotidine—Headache—Captopril—systemic scleroderma	0.00095	0.00095	CcSEcCtD
Famotidine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000949	0.000949	CcSEcCtD
Famotidine—Dyspepsia—Lisinopril—systemic scleroderma	0.000945	0.000945	CcSEcCtD
Famotidine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Famotidine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Famotidine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000941	0.000941	CcSEcCtD
Famotidine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000941	0.000941	CcSEcCtD
Famotidine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000935	0.000935	CcSEcCtD
Famotidine—Decreased appetite—Lisinopril—systemic scleroderma	0.000934	0.000934	CcSEcCtD
Famotidine—Fatigue—Lisinopril—systemic scleroderma	0.000926	0.000926	CcSEcCtD
Famotidine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000926	0.000926	CcSEcCtD
Famotidine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000921	0.000921	CcSEcCtD
Famotidine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000921	0.000921	CcSEcCtD
Famotidine—Pain—Lisinopril—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Famotidine—Constipation—Lisinopril—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Famotidine—Bradycardia—Prednisone—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Famotidine—Diarrhoea—Azathioprine—systemic scleroderma	0.000906	0.000906	CcSEcCtD
Famotidine—Nausea—Captopril—systemic scleroderma	0.000901	0.000901	CcSEcCtD
Famotidine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Famotidine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000897	0.000897	CcSEcCtD
Famotidine—Asthenia—Leflunomide—systemic scleroderma	0.000897	0.000897	CcSEcCtD
Famotidine—Hallucination—Prednisone—systemic scleroderma	0.000893	0.000893	CcSEcCtD
Famotidine—Pancytopenia—Methotrexate—systemic scleroderma	0.00089	0.00089	CcSEcCtD
Famotidine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Famotidine—Pruritus—Leflunomide—systemic scleroderma	0.000884	0.000884	CcSEcCtD
Famotidine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000878	0.000878	CcSEcCtD
Famotidine—Dysuria—Methotrexate—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Famotidine—Neutropenia—Methotrexate—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Famotidine—Dizziness—Azathioprine—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Famotidine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000871	0.000871	CcSEcCtD
Famotidine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Famotidine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Famotidine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Famotidine—Diarrhoea—Leflunomide—systemic scleroderma	0.000855	0.000855	CcSEcCtD
Famotidine—Urticaria—Lisinopril—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Famotidine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000851	0.000851	CcSEcCtD
Famotidine—Abdominal pain—Lisinopril—systemic scleroderma	0.000849	0.000849	CcSEcCtD
Famotidine—Body temperature increased—Lisinopril—systemic scleroderma	0.000849	0.000849	CcSEcCtD
Famotidine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Famotidine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Famotidine—Vomiting—Azathioprine—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Famotidine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Famotidine—Rash—Azathioprine—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Famotidine—Dermatitis—Azathioprine—systemic scleroderma	0.000834	0.000834	CcSEcCtD
Famotidine—Depression—Methotrexate—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Famotidine—Flushing—Prednisone—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Famotidine—Headache—Azathioprine—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Famotidine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Famotidine—Dizziness—Leflunomide—systemic scleroderma	0.000827	0.000827	CcSEcCtD
Famotidine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Famotidine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Famotidine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000805	0.000805	CcSEcCtD
Famotidine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000805	0.000805	CcSEcCtD
Famotidine—Arrhythmia—Prednisone—systemic scleroderma	0.000802	0.000802	CcSEcCtD
Famotidine—Haematuria—Methotrexate—systemic scleroderma	0.000797	0.000797	CcSEcCtD
Famotidine—Vomiting—Leflunomide—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Famotidine—Alopecia—Prednisone—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Famotidine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Famotidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Famotidine—Rash—Leflunomide—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Famotidine—Dermatitis—Leflunomide—systemic scleroderma	0.000787	0.000787	CcSEcCtD
Famotidine—Mental disorder—Prednisone—systemic scleroderma	0.000787	0.000787	CcSEcCtD
Famotidine—Nausea—Azathioprine—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Famotidine—Headache—Leflunomide—systemic scleroderma	0.000783	0.000783	CcSEcCtD
Famotidine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Famotidine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Famotidine—Asthenia—Lisinopril—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Famotidine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000769	0.000769	CcSEcCtD
Famotidine—Pruritus—Lisinopril—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Famotidine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Famotidine—Rash—Mycophenolic acid—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Famotidine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Famotidine—Hepatitis—Methotrexate—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Famotidine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Famotidine—Headache—Mycophenolic acid—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Famotidine—Pharyngitis—Methotrexate—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Famotidine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000744	0.000744	CcSEcCtD
Famotidine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000744	0.000744	CcSEcCtD
Famotidine—Nausea—Leflunomide—systemic scleroderma	0.000742	0.000742	CcSEcCtD
Famotidine—Diarrhoea—Lisinopril—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Famotidine—Anaemia—Prednisone—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Famotidine—Agitation—Prednisone—systemic scleroderma	0.000718	0.000718	CcSEcCtD
Famotidine—Angioedema—Prednisone—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Famotidine—Dizziness—Lisinopril—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Famotidine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Famotidine—Nausea—Mycophenolic acid—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Famotidine—Syncope—Prednisone—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Famotidine—Tinnitus—Methotrexate—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Famotidine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Famotidine—Loss of consciousness—Prednisone—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Famotidine—Vomiting—Lisinopril—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Famotidine—Rash—Lisinopril—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Famotidine—Convulsion—Prednisone—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Famotidine—Dermatitis—Lisinopril—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Famotidine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Famotidine—Headache—Lisinopril—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Famotidine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Famotidine—Arthralgia—Prednisone—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Famotidine—Myalgia—Prednisone—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Famotidine—Anxiety—Prednisone—systemic scleroderma	0.000663	0.000663	CcSEcCtD
Famotidine—Alopecia—Methotrexate—systemic scleroderma	0.000663	0.000663	CcSEcCtD
Famotidine—Mental disorder—Methotrexate—systemic scleroderma	0.000657	0.000657	CcSEcCtD
Famotidine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Famotidine—Dysgeusia—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Famotidine—Nausea—Lisinopril—systemic scleroderma	0.000638	0.000638	CcSEcCtD
Famotidine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000638	0.000638	CcSEcCtD
Famotidine—Oedema—Prednisone—systemic scleroderma	0.000638	0.000638	CcSEcCtD
Famotidine—Infection—Prednisone—systemic scleroderma	0.000634	0.000634	CcSEcCtD
Famotidine—Back pain—Methotrexate—systemic scleroderma	0.000632	0.000632	CcSEcCtD
Famotidine—Shock—Prednisone—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Famotidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Famotidine—Anorexia—Prednisone—systemic scleroderma	0.000608	0.000608	CcSEcCtD
Famotidine—Anaemia—Methotrexate—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Famotidine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000598	0.000598	CcSEcCtD
Famotidine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000593	0.000593	CcSEcCtD
Famotidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000593	0.000593	CcSEcCtD
Famotidine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00059	CcSEcCtD
Famotidine—Leukopenia—Methotrexate—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Famotidine—Insomnia—Prednisone—systemic scleroderma	0.000577	0.000577	CcSEcCtD
Famotidine—Paraesthesia—Prednisone—systemic scleroderma	0.000573	0.000573	CcSEcCtD
Famotidine—Cough—Methotrexate—systemic scleroderma	0.00057	0.00057	CcSEcCtD
Famotidine—Convulsion—Methotrexate—systemic scleroderma	0.000566	0.000566	CcSEcCtD
Famotidine—Dyspepsia—Prednisone—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Famotidine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Famotidine—Arthralgia—Methotrexate—systemic scleroderma	0.000556	0.000556	CcSEcCtD
Famotidine—Chest pain—Methotrexate—systemic scleroderma	0.000556	0.000556	CcSEcCtD
Famotidine—Myalgia—Methotrexate—systemic scleroderma	0.000556	0.000556	CcSEcCtD
Famotidine—Decreased appetite—Prednisone—systemic scleroderma	0.000554	0.000554	CcSEcCtD
Famotidine—Fatigue—Prednisone—systemic scleroderma	0.00055	0.00055	CcSEcCtD
Famotidine—Constipation—Prednisone—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Famotidine—Confusional state—Methotrexate—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Famotidine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Famotidine—Infection—Methotrexate—systemic scleroderma	0.00053	0.00053	CcSEcCtD
Famotidine—Feeling abnormal—Prednisone—systemic scleroderma	0.000526	0.000526	CcSEcCtD
Famotidine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Famotidine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Famotidine—Anorexia—Methotrexate—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Famotidine—Urticaria—Prednisone—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Famotidine—Abdominal pain—Prednisone—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Famotidine—Body temperature increased—Prednisone—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Famotidine—Insomnia—Methotrexate—systemic scleroderma	0.000482	0.000482	CcSEcCtD
Famotidine—Paraesthesia—Methotrexate—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Famotidine—Somnolence—Methotrexate—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Famotidine—Hypersensitivity—Prednisone—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Famotidine—Dyspepsia—Methotrexate—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Famotidine—Decreased appetite—Methotrexate—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Famotidine—Fatigue—Methotrexate—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Famotidine—Asthenia—Prednisone—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Famotidine—Pain—Methotrexate—systemic scleroderma	0.000456	0.000456	CcSEcCtD
Famotidine—Pruritus—Prednisone—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Famotidine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Famotidine—Diarrhoea—Prednisone—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Famotidine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Famotidine—Urticaria—Methotrexate—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Famotidine—Dizziness—Prednisone—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Famotidine—Body temperature increased—Methotrexate—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Famotidine—Abdominal pain—Methotrexate—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Famotidine—Vomiting—Prednisone—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Famotidine—Rash—Prednisone—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Famotidine—Dermatitis—Prednisone—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Famotidine—Headache—Prednisone—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Famotidine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Famotidine—Asthenia—Methotrexate—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Famotidine—Nausea—Prednisone—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Famotidine—Pruritus—Methotrexate—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Famotidine—Diarrhoea—Methotrexate—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Famotidine—Dizziness—Methotrexate—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Famotidine—Vomiting—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Famotidine—Rash—Methotrexate—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Famotidine—Dermatitis—Methotrexate—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Famotidine—Headache—Methotrexate—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Famotidine—Nausea—Methotrexate—systemic scleroderma	0.000317	0.000317	CcSEcCtD
